ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Building A Scalable Oncology Engine In A Dynamic Market

  Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly scale the number of oncology trials it could concurrently conduct.

• From Data Delays To Decision Speed

  The biggest risk in modern trials isn’t missing data. It’s delayed insight. Discover how real-time intelligence helps teams act faster, reduce risk, and improve trial execution.

• Do CROs Need To Reinvent Themselves In 2025?

  Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.

• The Benefits Of Next-Generation SAAS Have Arrived

  See how life science companies are using software as a service (SaaS) to bring new benefits to study startup, data collection, and more with this short blog.

• How Vanguard Clinical Harnesses CDMS/EDC For Faster Results

  Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.

• Digital Health Solution For CRS Detection And Prediction

  Explore how digital health technologies offer a data-driven solution to cytokine release syndrome (CRS) monitoring, reducing inpatient care requirements while ensuring patient safety.

• What Is ePRO?

  Real-time patient reporting improves data quality and trial insight. Digital tools cut missing data, enable remote participation, and clarify how treatments affect daily life.

• Paper COAs In 2026? It's Not "Cheaper," It's Riskier

  Paper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.

• A Guide To Medical Coding In Clinical Trials

  Medical coding transforms free-text clinical data into standardized terminology, enabling consistent analysis, safety monitoring, and regulatory review. Clear guidelines and quality control help reduce variability and protect data integrity across the entire clinical trial lifecycle.

• Implementing ICH E6 (R3) In A Risk Averse Culture

  Get several pointers on how to facilitate a transition to an agile, multi-faceted, and continuous risk and issue management approach aligned with the Statistical Analysis Plan.